At-Home Testing. Newly authorized for use, at-home testing kits are available through prescription. Learn more about where to get one, how to collect specimens and reporting results on this website from the Centers for Disease Control and Prevention (CDC). (December 30, 2020)

Rapid Expert Consultation on Critical Issues in Diagnostic Testing for the COVID-19 Pandemic. This report from the National Academies of Science, Engineering and Medicine’s Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats reviews four key areas of diagnostic testing development within the framework of strategies aimed at reducing disease burden of SARS-CoV-2. The paper highlights considerations for RT-PCR testing for viral RNA, point-of-care (POC) testing, testing strategies, and next generation testing. To read the paper, click here. (November 9, 2020)

LabCorp COVID-19 RT-PCR Test EUA Summary. Originally intended for testing of individuals suspected of having acquired COVID-19, the LabCorp COVID-19 RT-PCR Diagnostic Test (molecular) is now authorized through FDA Emergency Use Authorization for use by the general public and for sample pool testing. Learn more about the intended use of the test, and the directions for use and interpretation by clicking here. (November 4, 2020)

COVID-19 & Lab Testing Requirements Toolkit. The ADA offers a step-by-step guide of the application process for federal certification to offer COVID-19 rapid response testing for your patients. The toolkit can be accessed here and includes information about the following areas:

  • The Clinical Laboratory Improvements Amendments (CLIA)
  • State laboratory testing regulations
  • How to apply for a Federal Certificate of Waiver
  • Test reporting requirements